AST 0 3 0 3 B-clinical_variable
( 4 5 4 5 I-clinical_variable
SGOT 5 9 5 9 I-clinical_variable
) 9 10 9 10 I-clinical_variable
and 11 14 11 14 O
ALT 15 18 15 18 B-clinical_variable
( 19 20 19 20 I-clinical_variable
SGPT 20 24 20 24 I-clinical_variable
) 24 25 24 25 I-clinical_variable
≤ 26 27 26 27 O
2.5 28 31 28 31 B-upper_bound
x 32 33 32 33 I-upper_bound
ULN 34 37 34 37 I-upper_bound

Acceptable 0 10 38 48 O
renal 11 16 49 54 O
function 17 25 55 63 O
with 26 30 64 68 O
serum 31 36 69 74 B-clinical_variable
creatinine 37 47 75 85 I-clinical_variable
≤ 48 49 86 87 O
1.5 50 53 88 91 B-lower_bound
x 54 55 92 93 I-lower_bound
ULN 56 59 94 97 I-lower_bound
or 60 62 98 100 O
a 63 64 101 102 O
calculated 65 75 103 113 B-clinical_variable
creatinine 76 86 114 124 I-clinical_variable
clearance 87 96 125 134 I-clinical_variable
≥ 97 98 135 136 O
60 99 101 137 139 B-lower_bound
mL 102 104 140 142 I-lower_bound
/ 104 105 142 143 I-lower_bound
min 105 108 143 146 I-lower_bound
using 109 114 147 152 O
the 115 118 153 156 O
Cockcroft 119 128 157 166 O
- 128 129 166 167 O
Gault 129 134 167 172 O

Active 0 6 173 179 O
and 7 10 180 183 O
uncontrolled 11 23 184 196 O
bacterial 24 33 197 206 B-chronic_disease
, 33 34 206 207 O
viral 35 40 208 213 B-chronic_disease
, 40 41 213 214 O
or 42 44 215 217 O
fungal 45 51 218 224 B-chronic_disease
infections 52 62 225 235 I-chronic_disease
, 62 63 235 236 O
requiring 64 73 237 246 O
systemic 74 82 247 255 B-treatment
therapy 83 90 256 263 I-treatment

Active 0 6 264 270 B-chronic_disease
coronary 7 15 271 279 I-chronic_disease
artery 16 22 280 286 I-chronic_disease
disease 23 30 287 294 I-chronic_disease
requiring 31 40 295 304 O
treatment 41 50 305 314 B-treatment

Active 0 6 315 321 B-cancer
, 6 7 321 322 I-cancer
concurrent 8 18 323 333 I-cancer
malignancy 19 29 334 344 I-cancer
requiring 30 39 345 354 O
radiation 40 49 355 364 B-treatment
, 49 50 364 365 O
chemotherapy 51 63 366 378 B-treatment
, 63 64 378 379 O
or 65 67 380 382 O
immunotherapy 68 81 383 396 B-treatment

At 0 2 397 399 O
least 3 8 400 405 O
1 9 10 406 407 B-lower_bound
week 11 15 408 412 I-lower_bound
since 16 21 413 418 O
the 22 25 419 422 O
last 26 30 423 427 O
systemic 31 39 428 436 B-treatment
therapy 40 47 437 444 I-treatment
regimen 48 55 445 452 O
prior 56 61 453 458 O
to 62 64 459 461 O
Cycle 65 70 462 467 O
1 71 72 468 469 O
Day 73 76 470 473 O
1 77 78 474 475 O

Both 0 4 476 480 O
females 5 12 481 488 B-gender
and 13 16 489 492 I-gender
male 17 21 493 497 I-gender
subjects 22 30 498 506 I-gender
with 31 35 507 511 O
female 36 42 512 518 O
partners 43 51 519 527 O
of 52 54 528 530 O
child 55 60 531 536 O
- 60 61 536 537 O
bearing 61 68 537 544 O
potential 69 78 545 554 O
must 79 83 555 559 O
agree 84 89 560 565 B-contraception_consent
to 90 92 566 568 I-contraception_consent
use 93 96 569 572 I-contraception_consent
an 97 99 573 575 I-contraception_consent
adequate 100 108 576 584 I-contraception_consent
method 109 115 585 591 I-contraception_consent
of 116 118 592 594 I-contraception_consent
contraception 119 132 595 608 I-contraception_consent
for 133 136 609 612 O
2 137 138 613 614 B-upper_bound
weeks 139 144 615 620 I-upper_bound
prior 145 150 621 626 I-upper_bound
to 151 153 627 629 O
screening 154 163 630 639 O
, 163 164 639 640 O
during 165 171 641 647 O
, 171 172 647 648 O
and 173 176 649 652 O
at 177 179 653 655 O
least 180 185 656 661 O
4 186 187 662 663 B-lower_bound
weeks 188 193 664 669 I-lower_bound
after 194 199 670 675 O
last 200 204 676 680 O
dose 205 209 681 685 O
of 210 212 686 688 O
study 213 218 689 694 O
medication 219 229 695 705 O

Concomitant 0 11 706 717 B-chronic_disease
disease 12 19 718 725 I-chronic_disease
or 20 22 726 728 O
condition 23 32 729 738 O
that 33 37 739 743 O
could 38 43 744 749 O
interfere 44 53 750 759 O
with 54 58 760 764 O
the 59 62 765 768 O
conduct 63 70 769 776 O
of 71 73 777 779 O
the 74 77 780 783 O
study 78 83 784 789 O
, 83 84 789 790 O
or 85 87 791 793 O
that 88 92 794 798 O
would 93 98 799 804 O
, 98 99 804 805 O
in 100 102 806 808 O
the 103 106 809 812 O
opinion 107 114 813 820 O
of 115 117 821 823 O
the 118 121 824 827 O
investigator 122 134 828 840 O
, 134 135 840 841 O
pose 136 140 842 846 O
an 141 143 847 849 O
unacceptable 144 156 850 862 O
risk 157 161 863 867 O
to 162 164 868 870 O
the 165 168 871 874 O
subject 169 176 875 882 O
in 177 179 883 885 O
this 180 184 886 890 O
study 185 190 891 896 O

Concurrent 0 10 897 907 O
use 11 14 908 911 O
of 15 17 912 914 O
granulocyte 18 29 915 926 B-treatment
macrophage 30 40 927 937 I-treatment
colony 41 47 938 944 I-treatment
- 47 48 944 945 I-treatment
stimulating 48 59 945 956 I-treatment
factor 60 66 957 963 I-treatment
( 67 68 964 965 I-treatment
GM 68 70 965 967 I-treatment
- 70 71 967 968 I-treatment
CSF 71 74 968 971 I-treatment
) 74 75 971 972 I-treatment

Diagnosis 0 9 973 982 O
of 10 12 983 985 O
CMML 13 17 986 990 B-cancer
as 18 20 991 993 O
defined 21 28 994 1001 O
by 29 31 1002 1004 O
the 32 35 1005 1008 O
World 36 41 1009 1014 O
Health 42 48 1015 1021 O
Organization 49 61 1022 1034 O
( 62 63 1035 1036 O
WHO 63 66 1036 1039 O
) 66 67 1039 1040 O
criteria 68 76 1041 1049 O

Eastern 0 7 1050 1057 B-clinical_variable
Cooperative 8 19 1058 1069 I-clinical_variable
Oncology 20 28 1070 1078 I-clinical_variable
Group 29 34 1079 1084 I-clinical_variable
( 35 36 1085 1086 I-clinical_variable
ECOG 36 40 1086 1090 I-clinical_variable
) 40 41 1090 1091 I-clinical_variable
performance 42 53 1092 1103 I-clinical_variable
status 54 60 1104 1110 I-clinical_variable
0 61 62 1111 1112 B-lower_bound
or 63 65 1113 1115 O
1 66 67 1116 1117 B-upper_bound

Female 0 6 1118 1124 B-gender
subjects 7 15 1125 1133 I-gender
must 16 20 1134 1138 O
have 21 25 1139 1143 O
a 26 27 1144 1145 O
negative 28 36 1146 1154 B-pregnancy
serum 37 42 1155 1160 I-pregnancy
or 43 45 1161 1163 I-pregnancy
urine 46 51 1164 1169 I-pregnancy
pregnancy 52 61 1170 1179 I-pregnancy
test 62 66 1180 1184 O
within 67 73 1185 1191 O
72 74 76 1192 1194 B-upper_bound
hours 77 82 1195 1200 I-upper_bound
prior 83 88 1201 1206 I-upper_bound
to 89 91 1207 1209 O
start 92 97 1210 1215 O
of 98 100 1216 1218 O
study 101 106 1219 1224 O
medication 107 117 1225 1235 O

Major 0 5 1236 1241 B-treatment
surgery 6 13 1242 1249 I-treatment
, 13 14 1249 1250 O
other 15 20 1251 1256 O
than 21 25 1257 1261 O
diagnostic 26 36 1262 1272 B-treatment
surgery 37 44 1273 1280 I-treatment
, 44 45 1280 1281 O
within 46 52 1282 1288 O
2 53 54 1289 1290 B-upper_bound
weeks 55 60 1291 1296 I-upper_bound
prior 61 66 1297 1302 I-upper_bound
to 67 69 1303 1305 O
Cycle 70 75 1306 1311 O
1 76 77 1312 1313 O
Day 78 81 1314 1317 O
1 82 83 1318 1319 O
, 83 84 1319 1320 O
without 85 92 1321 1328 O
complete 93 101 1329 1337 O
recovery 102 110 1338 1346 O

Modification 0 12 1347 1359 O
of 13 15 1360 1362 O
Diet 16 20 1363 1367 O
in 21 23 1368 1370 O
Renal 24 29 1371 1376 B-chronic_disease
Disease 30 37 1377 1384 I-chronic_disease
formulas 38 46 1385 1393 O

Myeloproliferative 0 18 1394 1412 B-chronic_disease
/ 18 19 1412 1413 O
myelodysplastic 19 34 1413 1428 B-chronic_disease
syndrome 35 43 1429 1437 I-chronic_disease
other 44 49 1438 1443 O
than 50 54 1444 1448 O
CMML 55 59 1449 1453 B-cancer

New 0 3 1454 1457 O
York 4 8 1458 1462 O
Heart 9 14 1463 1468 O
Association 15 26 1469 1480 O
grade 27 32 1481 1486 O
III 33 36 1487 1490 O
or 37 39 1491 1493 O
greater 40 47 1494 1501 O
congestive 48 58 1502 1512 B-chronic_disease
heart 59 64 1513 1518 I-chronic_disease
failure 65 72 1519 1526 I-chronic_disease

Ongoing 0 7 1527 1534 O
treatment 8 17 1535 1544 B-treatment
with 18 22 1545 1549 O
an 23 25 1550 1552 O
anticancer 26 36 1553 1563 B-treatment
agent 37 42 1564 1569 I-treatment
for 43 46 1570 1573 O
CMML 47 51 1574 1578 B-cancer
not 52 55 1579 1582 O
contemplated 56 68 1583 1595 O
in 69 71 1596 1598 O
this 72 76 1599 1603 O
protocol 77 85 1604 1612 O

Participation 0 13 1613 1626 O
in 14 16 1627 1629 O
any 17 20 1630 1633 O
interventional 21 35 1634 1648 O
study 36 41 1649 1654 O
within 42 48 1655 1661 O
4 49 50 1662 1663 B-upper_bound
weeks 51 56 1664 1669 I-upper_bound
of 57 59 1670 1672 O
randomization 60 73 1673 1686 O
or 74 76 1687 1689 O
5 77 78 1690 1691 O
half 79 83 1692 1696 O
- 83 84 1696 1697 O
lives 84 89 1697 1702 O
of 90 92 1703 1705 O
the 93 96 1706 1709 O
prior 97 102 1710 1715 O
treatment 103 112 1716 1725 O
agent 113 118 1726 1731 O
( 119 120 1732 1733 O
whichever 120 129 1733 1742 O
is 130 132 1743 1745 O
longer 133 139 1746 1752 O
) 139 140 1752 1753 O

Prior 0 5 1754 1759 B-treatment
treatment 6 15 1760 1769 I-treatment
( 16 17 1770 1771 O
at 17 19 1771 1773 O
least 20 25 1774 1779 O
1 26 27 1780 1781 B-lower_bound
full 28 32 1782 1786 O
treatment 33 42 1787 1796 O
cycle 43 48 1797 1802 O
) 48 49 1802 1803 O
with 50 54 1804 1808 O
a 55 56 1809 1810 O
farnesyltransferase 57 76 1811 1830 B-treatment
inhibitor 77 86 1831 1840 I-treatment

Subjects 0 8 1841 1849 O
must 9 13 1850 1854 O
have 14 18 1855 1859 O
recovered 19 28 1860 1869 O
to 29 31 1870 1872 O
NCI 32 35 1873 1876 B-clinical_variable
CTCAE 36 41 1877 1882 I-clinical_variable
v. 42 44 1883 1885 I-clinical_variable
4.03 45 49 1886 1890 I-clinical_variable
< 50 51 1891 1892 O
Grade 52 57 1893 1898 B-upper_bound
2 58 59 1899 1900 I-upper_bound
from 60 64 1901 1905 O
all 65 68 1906 1909 O
acute 69 74 1910 1915 O
toxicities 75 85 1916 1926 O

Total 0 5 1927 1932 B-clinical_variable
or 6 8 1933 1935 I-clinical_variable
direct 9 15 1936 1942 I-clinical_variable
bilirubin 16 25 1943 1952 I-clinical_variable
≤ 26 27 1953 1954 O
2 28 29 1955 1956 B-upper_bound
times 30 35 1957 1962 I-upper_bound
upper 36 41 1963 1968 I-upper_bound
limit 42 47 1969 1974 I-upper_bound
of 48 50 1975 1977 I-upper_bound
normal 51 57 1978 1984 I-upper_bound
( 58 59 1985 1986 I-upper_bound
x 59 60 1986 1987 I-upper_bound
ULN 61 64 1988 1991 I-upper_bound
) 64 65 1991 1992 I-upper_bound

active 0 6 1993 1999 B-chronic_disease
infection 7 16 2000 2009 I-chronic_disease
with 17 21 2010 2014 O
hepatitis 22 31 2015 2024 B-chronic_disease
B 32 33 2025 2026 I-chronic_disease
or 34 36 2027 2029 O
hepatitis 37 46 2030 2039 B-chronic_disease
C 47 48 2040 2041 I-chronic_disease

adjuvant 0 8 2042 2050 B-treatment
hormonal 9 17 2051 2059 I-treatment
therapy 18 25 2060 2067 I-treatment
for 26 29 2068 2071 O
breast 30 36 2072 2078 B-cancer
cancer 37 43 2079 2085 I-cancer

at 0 2 2086 2088 O
least 3 8 2089 2094 O
2 9 10 2095 2096 B-lower_bound
years 11 16 2097 2102 I-lower_bound
post 17 21 2103 2107 O
- 21 22 2107 2108 O
menopausal 22 32 2108 2118 O

cerebro 0 7 2119 2126 B-chronic_disease
- 7 8 2126 2127 I-chronic_disease
vascular 8 16 2127 2135 I-chronic_disease
attack 17 23 2136 2142 O
within 24 30 2143 2149 O
the 31 34 2150 2153 O
prior 35 40 2154 2159 B-upper_bound
year 41 45 2160 2164 I-upper_bound

current 0 7 2165 2172 O
serious 8 15 2173 2180 O
cardiac 16 23 2181 2188 B-chronic_disease
arrhythmia 24 34 2189 2199 I-chronic_disease
requiring 35 44 2200 2209 O
medication 45 55 2210 2220 O
except 56 62 2221 2227 O
atrial 63 69 2228 2234 O
fibrillation 70 82 2235 2247 O

myocardial 0 10 2248 2258 B-chronic_disease
infarction 11 21 2259 2269 I-chronic_disease
within 22 28 2270 2276 O
the 29 32 2277 2280 O
prior 33 38 2281 2286 O
year 39 43 2287 2291 O

non 0 3 2292 2295 B-cancer
- 3 4 2295 2296 I-cancer
melanoma 4 12 2296 2304 I-cancer
skin 13 17 2305 2309 I-cancer
cancer 18 24 2310 2316 I-cancer

subjects 0 8 2317 2325 O
with 9 13 2326 2330 O
Gilbert 14 21 2331 2338 B-chronic_disease
's 21 23 2338 2340 I-chronic_disease
syndrome 24 32 2341 2349 I-chronic_disease
diagnosed 33 42 2350 2359 O
as 43 45 2360 2362 O
per 46 49 2363 2366 O
institutional 50 63 2367 2380 O
guidelines 64 74 2381 2391 O

